TAKE CONTROL AND TREAT MGD WITH CONFIDENCE
For personalized, MGD treatment, the iLUX®device with its advanced Smart Tip Patient Interface, gives you results you can see.
important safety Information
Scroll to Learn More
IMPORTANT PRODUCT Information
REFERENCES
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
©2020 Alcon Inc. 2/20 US-ILU-1900084
MEIBOMIAN GLAND DYSFUNCTION (MGD) IS A CHRONIC DISEASE
TO DATE, IT HAS NO PERMANENT CURE
THE iLUX® SUITE OF THREE INNOVATIONS
Embrace Alcon’s dry eye suite to have the tools you need to help tackle MGD—from start to finish.
HOW IT WORKS
SEE IT. HEAT IT. TREAT IT. PERSONALIZE IT.
Reach and Treat the Patients That Need It Most
The DEEP™ program is a core component of your iLUX® purchase. Gain best-in-class dry eye management, as well as the practice and patient interaction tools needed for success.
Demonstrated Efficacy With iLUX®
iLUX® was shown to be equivalent to LipiFlow† and produced statistically significant improvement in signs and symptoms of MGD vs baseline.
Patient Symptoms were evaluated based on validated OSDI symptom questionnaire. MGS was used to score the presence and quality of gland secretions. TBUT was used to measure tear film stability time.
Help your patients treat their dry eye symptoms at home with Systane® lubricating eye drops.
OVER 30 MILLION PEOPLE IN THE US SUFFER FROM DRY EYE
86% OF DRY EYE PATIENTS HAVE SIGNS OF MGD
iLUX® MGD Treatment Device
Gain control to confidently deliver outstanding MGD treatment
Learn More
1-Click Smart Tip Patient Interface
Bring advanced technology to the site of treatment
Learn More
Dry Eye Excellence Program (DEEP™)
Partner with Alcon to successfully meet your patient goals
Learn More
The 1-Click Smart Tip Patient Interface and iLUX® MGD Treatment Device come together for effective MGD treatment that only takes 8-12 minutes.
1-Click Smart Tip Patient Interface
• Set up with one click–it takes less than a minute
• Heat and pressure levels are continually monitored by precision sensors
• Eyelid pads are covered with a soft, biocompatible silicone material for patient comfort
iLUX® MGD Treatment Device
• Visualize treatment zones to target blocked meibomian glands
• Personalize treatment to respond to patient feedback
• It's portable - you control when and where you treat your patient in your office
iLUX® in Action
To Learn More About iLUX®, Contact Your Local Account Manager
If you do not have an Account Manager, please call Alcon Customer Service at 1 (800) 241-5999.
Patient Symptoms (OSDI)
Meibomian Gland Score
*p < 0.0001, compared to baseline
*p < 0.0001, compared to baseline
Tear Breakup Time (Both Eyes)
*p < 0.0001, compared to baseline
*Based on a prospective, randomized, open-label, multi-center, bilateral treatment, clinical trial in 142 subjects comparing changes in MGD and patient symptoms following treatment with iLUX® and LipiFlow devices.
†LipiFlow is a trademark of Johnson & Johnson Vision Care, Inc.
THE #1 DOCTOR RECOMMENDED BRAND OF ARTIFICIAL TEARS
To Learn More About iLUX®, Contact Your Local Account Manager
If you do not have an Account Manager, please call Alcon Customer Service at 1 (800) 241-5999.
Learn More About Systane®
Learn More About Systane®
References
References:
1. Tear Film and Ocular Surface Society (TFOS). TFOS DEWS II. Available at http://www.tearfilm.org/dettreports-tfos_dew_ii_report/32_30/eng/. Accessed May 9, 2018.
2. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31(5):472-478. doi:10.1097/ICO.0b013e318225415a.
3. Nichols, K. K., et al. (2011). "The International Workshop on Meibomian Gland Dysfunction: Executive Summary.
4. Hardten DR, Schanzlin DJ, Dishler JG, et al. Comparison of a handheld infrared heating and compression device and a thermal pulsation device to treat meibomian gland dysfunction. Paper presented at: 2018 American Society of Cataract and Refractive Surgery–American Society of Ophthalmic Administrators Annual Meeting; April 16, 2018; Washington, DC.
5. Alcon data on file, 2018.
IMPORTANT PRODUCT INFORMATION
IMPORTANT PRODUCT INFORMATION FOR iLUX® DEVICE
Indication
The iLUX® Device is indicated for the application of localized heat and pressure therapy in adult patients with chronic disease of the eyelids, including Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye.
Contraindications
Do NOT use the iLUX® Device in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients who have undergone ocular surgery within prior 12 months; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or patients with permanent makeup or tattoos on their eyelids.
Warnings/Precautions
Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the iLUX® device is NOT recommended in patients with the following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions that cause dry eye; in patients who are taking medications known to cause dryness; or patients with punctal plugs.
Potential Adverse Reactions
Potential adverse effects may include eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctive edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).
ATTENTION: PLEASE REFER TO THE USER MANUAL FOR A COMPLETE LIST OF CONTRAINDICATIONS, INSTRUCTIONS FOR USE, WARNINGS AND PRECAUTIONS FOR THE iLUX® DEVICE.
4-9
4-6
7
10
8
8
2
1
1
8,9,11,12
8,9,11,12
13,14
3,7,15
4-6
11
12
13,14
4,16,17
4,18
19
20
11
12,13
14
1-3
4
2
2
2
21
5
22
10
10
10
1-3
23
23
24
Help your patients treat their dry eye symptoms at home with Systane® lubricating eye drops.
IMPORTANT PRODUCT INFORMATION
IMPORTANT PRODUCT INFORMATION FOR iLUX® DEVICE
Indication
The iLUX® Device is indicated for the application of localized heat and pressure therapy in adult patients with chronic disease of the eyelids,
including Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye.
Contraindications
Do NOT use the iLUX® Device in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients who
have undergone ocular surgery within prior 12 months; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency
(within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients
with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular
inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or patients with permanent makeup or tattoos on their eyelids.
Warnings/Precautions
Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.
The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the iLUX® device is NOT recommended in patients with the
following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions
that cause dry eye; in patients who are taking medications known to cause dryness; or patients with punctal plugs.
Potential Adverse Reactions
Potential adverse effects may include eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation,
temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctive edema or conjunctival injection
(hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance,
sensitivity to light).
ATTENTION: PLEASE REFER TO THE USER MANUAL FOR A COMPLETE LIST OF CONTRAINDICATIONS, INSTRUCTIONS FOR USE, WARNINGS AND PRECAUTIONS FOR THE iLUX® DEVICE.
3
3
IMPORTANT PRODUCT INFORMATION
IMPORTANT PRODUCT INFORMATION FOR iLUX® DEVICE
Indication
The iLUX® Device is indicated for the application of localized heat and pressure therapy in adult patients with chronic disease of the eyelids, including Meibomian Gland Dysfunction (MGD), also known as evaporative dry eye.
Contraindications
Do NOT use the iLUX® Device in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients who have undergone ocular surgery within prior 12 months; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or patients with permanent makeup or tattoos on their eyelids.
Warnings/Precautions
Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner. The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the iLUX® device is NOT recommended in patients with the following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions that cause dry eye; in patients who are taking medications known to cause dryness; or patients with punctal plugs.
Potential Adverse Reactions
Potential adverse effects may include eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctive edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).
ATTENTION: PLEASE REFER TO THE USER MANUAL FOR A COMPLETE LIST OF CONTRAINDICATIONS, INSTRUCTIONS FOR USE, WARNINGS AND PRECAUTIONS FOR THE iLUX® DEVICE.
*